Risk factors for fatal and non-fatal cardiovascular events in 9306 subjects in the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial

Risk factors for fatal and non-fatal cardiovascular events in 9306 subjects in the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial

書誌詳細
主要な著者:	Mcmurray, J, Laakso, M, Standl, E, Tognoni, G, Holman, R, Giles, T, Martinez, F, Thomas, L, Haffner, S, Califf, R
フォーマット:	Journal article
出版事項:	2011

類似資料

Predictors of stroke in patients with impaired glucose tolerance: results from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial.
著者:: Preiss, D, 等
出版事項: (2013)

Predictors of cardiovascular events in a contemporary population with impaired glucose tolerance: an observational analysis of the Nateglinide and Valsartan in impaired glucose tolerance outcomes research (NAVIGATOR) trial
著者:: Preiss, D, 等
出版事項: (2012)

Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial.
著者:: Califf, R, 等
出版事項: (2008)

Baseline characteristics of the Nateglinide and Valsartan Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial population: comparison with other diabetes prevention trials.
著者:: Krum, H, 等
出版事項: (2010)

Incidence of atrial fibrillation in a population with impaired glucose tolerance: the contribution of glucose metabolism and other risk factors. A post hoc analysis of the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial.
著者:: Latini, R, 等
出版事項: (2013)

Noncardiovascular deaths are more common than cardiovascular deaths in patients with cardiovascular disease or cardiovascular risk factors and impaired glucose tolerance: Insights from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial.
著者:: Sharma, A, 等
出版事項: (2016)

Effect of valsartan on kidney outcomes in people with impaired glucose tolerance.
著者:: Currie, G, 等
出版事項: (2017)

People at increased risk of cardiovascular disease screened for the NAVIGATOR trial frequently have undiagnosed diabetes or impaired glucose tolerance
著者:: Califf, R, 等
出版事項: (2003)

Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): a cohort analysis.
著者:: Yates, T, 等
出版事項: (2014)

Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): A cohort analysis
著者:: Yates, T, 等
出版事項: (2014)

Effect of nateglinide on the incidence of diabetes and cardiovascular events.
著者:: Holman, R, 等
出版事項: (2010)

Diet and other health-related behaviors of individuals with impaired glucose tolerance, cardiovascular disease (CVD) or CVD risk: A global view from the NAVIGATOR study
著者:: Bales, C, 等
出版事項: (2013)

Cardiologists should care about glucose: most people with CV disease or risk factors have diabetes or significant glycaemic abnormalities. Results of screening over 39,000 subjects for NAVIGATOR
著者:: McMurray, J, 等
出版事項: (2004)

The effect of nateglinide stimulated insulin secretion on post challenge glucose and lipid metabolism in Type 2 diabetes
著者:: Mohanlal, N, 等
出版事項: (2002)

Do Diuretics, Beta-Blockers, and Statins Increase the Risk of Diabetes in Patients with Impaired Glucose Tolerance? Insights from the NAVIGATOR Study
著者:: Shen, L, 等
出版事項: (2012)

A novel risk classification paradigm for patients with impaired glucose tolerance and high cardiovascular risk
著者:: Bethel, M, 等
出版事項: (2013)

A novel risk classification paradigm for patients with impaired glucose tolerance and high cardiovascular risk.
著者:: Bethel, M, 等
出版事項: (2013)

Role of diuretics, β blockers, and statins in increasing the risk of diabetes in patients with impaired glucose tolerance: reanalysis of data from the NAVIGATOR study.
著者:: Shen, L, 等
出版事項: (2013)

Association of non-alcoholic steatothepatitis with components of the metabolic syndrome in 43,509 patients screened for NAVIGATOR
著者:: Bethel, A, 等
出版事項: (2005)

Effect of Valsartan on the Incidence of Diabetes REPLY
著者:: Holman, R, 等
出版事項: (2010)

Prediabetes and the risk of diabetes.
著者:: McMurray, J, 等
出版事項: (2012)

Frequency of abnormal glucose tolerance and the metabolic syndrome in people at increased cardiovascular disease risk screened for the NAVIGATOR trial
著者:: Holman, R, 等
出版事項: (2003)

International variation in outcomes among people with cardiovascular disease or cardiovascular risk factors and impaired glucose tolerance: Insights from the NAVIGATOR Trial.
著者:: Dos Santos, M, 等
出版事項: (2017)

Effects of Glucose Load and Nateglinide Intervention on Endothelial Function and Oxidative Stress
著者:: Leilei Wang, 等
出版事項: (2013-01-01)

Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers for Hypertension on Clinical End Points: A Cohort Study
著者:: Mcmurray, J, 等
出版事項: (2012)

Predicting heart failure events in patients with coronary heart disease and impaired glucose tolerance: insights from the Acarbose Cardiovascular Evaluation (ACE) trial
著者:: Wamil, M, 等
出版事項: (2020)

Risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes: UKPDS 66.
著者:: Stevens, R, 等
出版事項: (2004)

Chronic obstructive pulmonary disease and cardiovascular risk: insights from the NAVIGATOR trial.
著者:: de Barros e Silva, P, 等
出版事項: (2014)

Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for hypertension on clinical end points: a cohort study.
著者:: McMurray, J, 等
出版事項: (2012)

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial.
著者:: Gerstein, H, 等
出版事項: (2006)

Relations between Baseline Physical Activity by Pedometer Counts and Future Cardiovascular Events in the NAVIGATOR Study
著者:: Kraus, W, 等
出版事項: (2012)

Effect of valsartan on the incidence of diabetes and cardiovascular events.
著者:: McMurray, J, 等
出版事項: (2010)

Fatalism in systematic aspect and fatalism in its functional context
著者:: Gustav Henningsen
出版事項: (1967-01-01)

Change in levels of physical activity after diagnosis of type 2 diabetes: An observational analysis from the NAVIGATOR study
著者:: Preiss, D, 等
出版事項: (2014)

Fatalism and Savings
著者:: Shapiro, J
出版事項: (2011)

Fatal voyage /
著者:: 374399 Reichs, Kathy
出版事項: (2001)

Fatal embrace /
著者:: 510932 Whittier, Aris
出版事項: (2005)

Fatal incomprehension
著者:: McLoughlin, K
出版事項: (2018)

Fatal attraction
著者:: Mohtarrudin, Norhafizah
出版事項: (2015)

Fatal revenant /
著者:: Donaldson, Stephen